Burning Rock Biotech (BNR) Work In Process (2019 - 2025)

Burning Rock Biotech's Work In Process history runs 7 years deep, the most recent figure standing at $11.0 million for Q4 2025.

• In Q4 2025, Work In Process rose 4.27% year-over-year to $11.0 million; the TTM figure through Dec 2025 stood at $11.0 million (up 4.27% YoY), while the FY2025 annual figure was $11.1 million, up 7.47% from the prior year.
• Work In Process for Q4 2025 stood at $11.0 million, up from $10.5 million in the prior quarter.
• The five-year high for Work In Process was $11.3 million in Q4 2023, with the low at $3.8 million in Q1 2021.
• The 5-year median for Work In Process is $8.9 million (2021), against an average of $8.1 million.
• The sharpest annual moves came in 2021 and 2024: Work In Process soared 126.45% in 2021, then retreated 6.93% in 2024.
• Burning Rock Biotech's Work In Process stood at $8.9 million in 2021, then advanced by 22.55% to $10.9 million in 2022, then gained by 3.89% to $11.3 million in 2023, then retreated by 6.93% to $10.5 million in 2024, then grew by 4.27% to $11.0 million in 2025.
• Business Quant data shows BNR's Work In Process at $11.0 million in Q4 2025, $10.5 million in Q4 2024, and $11.3 million in Q4 2023.